Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Average Wholesale Pricing Economic Experts: Healthcare Consultants

Council Members in this Study Group: 20

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INCAdam Fein, PhD

Founder & President
PEMBROKE CONSULTING INC
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Adam Fein, PhD, is the Founder and President of Pembroke Consulting, Inc., a Philadelphia-based management advisory and business research firm. Dr. Fein is one of the country’s foremost experts on pharmacy economics and the pharmaceutical supply chain. He provides strategic advisory services to a diverse...

165 recent news post(s)
Bruce Goldberg

President
Pharmacy Benefit Advisors
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Bruce Goldberg is the President of Pharmacy Express Services and Pharmacy Benefit Advisors, both based in Omaha, Nebraska. He is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He developed a program which allows generic and therapeuticsubstitution...

1 recent news post(s)
Vikram Singh, MBA

Director in Health and Productivity Practice
Buck Consultants, LLC. (Mellon Consultants)
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Vikram Singh, MBA, is the Director in the Health and Productivity Practice at Buck Consultants. His expertise is in the financial and business aspects of pharmacy benefit management. Mr. Singh provides strategic advice in the areas of pharmacy benefit and health care finance, and on mergers and acquisitions...

David Zimmerman, PharmD

President/Owner
Doctors of Pharmacy, Inc.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30 years of experience, specializing in pharmacyservices...

9 recent news post(s)
Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM

Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Dea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...

4 recent news post(s)
2 recent event(s)
Steven Miller, MS, DPH, President, Steven Miller, MS, DPHSteven Miller, MS, DPH

President
Steven Miller, MS, DPH
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Steven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement issues, where he is working since February...

1 recent news post(s)
David Wright, President, Wright Consulting GroupDavid Wright

President
Wright Consulting Group
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Wright is the President at Wright Consulting Group, California, a company providing consulting services to the healthcare sector. He provides marketing support for retail pharmacy chains and independents. Mr. Wright negotiates contracts for purchasing branded and generic pharmaceuticals and puts...

Aemad Aslam, MBA

President
MindPharma
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Aemad Aslam, BPharm, MBA, RPh, is the President of MindPharma, a pharmacy and retail strategy consulting group. Most recently, he has consulted with a PBM, Prime Therapeutics, in Texas, a subsidiary of Blue Cross Blue Shield. He also has served as an Executive Team Leader for Pharmacy at the Target...

7 recent news post(s)

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone

April 13, 2009

Aemad Aslam, MBA, President, MindPharma

Sun Pharma gets USFDA's nod to market painkillers | www.hindu.com

Sun Pharma can greatly benefit from the nationwide shortage of Oxycodone Immediate Release Tablet, by getting approval from the FDA on their own generic. With recent recalls from different manufacturers, and the shortage of a comparable product Morphine Sulphate, the FDA currently estimates that return...

Aurobindo Pharma's Escitalopram will be a big mover ... when it comes out in 2011

March 5, 2009

Aemad Aslam, MBA, President, MindPharma

Aurobindo Pharma receives tentative approval for Escitalopram | www.indiainfoline.com

Forest's Lexapro commands a $2.5+ billion USD market share, just in the US.  Due to such a high volume of the brand product, Aurobindo's tentative approval on Lexapro's generic Escitalopram will be a great opportunity - primarily if they can procure a 6 month period of exclusivity from the FDA. ...

Teva's Generic Imitrex commands market of Sumatriptan

February 26, 2009

Aemad Aslam, MBA, President, MindPharma

Teva Announces Approval and Launch of Generic Imitrex(R) Tablets | www.pipelinereview.com

With the 180 day exclusivity, Teva is already commanding the market of the generic Imitrex - Sumatriptan oral tablets.  Teva maintains an AB rating of the generic that will render most insurance companies to push brand name Imitrex by GlaxoSmithKline to a non-formulary tier, skyrocketing the...

No Visible Revenue Synergies in CVS Caremark's Latest Numbers

February 23, 2009

Adam Fein, PhD, Founder & President, PEMBROKE CONSULTING INC

CVS Net Rises; Finance Chief Plans to Retire | online.wsj.com

CVS Caremark’s PBM businesses are not becoming a larger share of prescriptions filled at CVS retail pharmacies. Put another way, the flagship Maintenance Choice program may be appealing to payers and consumers, but there is not yet a quantitatively visible shift in CVS' retail activity. If CVS pharmacies...

Acquisitions of Indian Pharma on the extended horizon by Brand name pharma

February 23, 2009

Aemad Aslam, MBA, President, MindPharma

Pharma cos on lookout for Indian drug firms | economictimes.indiatimes.com

Acquisitions of various Indian generic pharmaceuticals is likely on the horizon for brand name manufacturers.  However, this is not an immediate concern.  I would see more consolidations in the US and other Western markets first. 

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Consultancy, Pharma-Focused
  • Consultancy, Healthcare-Focused
  • Healthcare Management
  • Individual/Small Consultancy
  • Actuarial Consulting
  • Pharmaceutical Benefits Manager, Small <10 M Lives
  • Pharmacy or Drug Store, Chain
  • Strategic Management

Members in this Study Group often have these job titles:

  • President
  • Owner
  • Consultant
  • Principal
  • Senior Vice President
  • Chief Operating Officer
  • Partner
  • Business Development Manager
  • Director

Related Study Groups

Study Group Name No. Members
Economic Experts on Pharmacy Benefit Management Services 90
Generic Drug Economic Experts 766
Economic Experts on Managed Care 714
Managed Care Experts 669
Formulary Design Experts 250
Biopharmaceutical Pricing Trend Experts (US) 24
Zocor Pricing Experts (US) 38

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Average Wholesale Pricing Economic Experts: Healthcare Consultants Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Average Wholesale Pricing Economic Experts: Healthcare Consultants have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare